Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease

Medicine and Dentistry

• Parkinson's Disease 100%
• Receptor 100%
• Neuroinflammation 100%
• Therapeutics 100%
• Peroxisome Proliferator-Activated Receptor 100%
• Dopamine 66%
• Inflammation 50%
• Treatment of Parkinson's Disease 50%
• Oxidative Stress 33%
• Dopaminergic Neuron 33%
• Pathology 16%
• Diseases 16%
• Therapeutic Procedure 16%
• Comprehension 16%
• Drug 16%
• Homeostasis 16%
• Mitochondrion 16%
• Neurodegeneration 16%
• Insulin Sensitivity 16%
• Neuroprotection 16%
• Nerve Cell Degeneration 16%
• Substantia nigra 16%
• Dopaminergic System 16%
• Symptom 16%
• Free Radical 16%

Neuroscience

• Eicosanoid Receptor 100%
• Parkinson's Disease 100%
• Peroxisome 100%
• Dopamine 66%
• Treatment of Parkinson's Disease 50%
• Dopaminergic Neuron 33%
• Oxidative Stress 33%
• Mitochondrion 16%
• Substantia nigra 16%
• Neuroprotection 16%
• Mitochondrial Function 16%
• Insulin 16%
• Dopaminergic 16%
• Free Radical 16%
• Nerve Cell Degeneration 16%
• Agonist 16%
• Neurodegeneration 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Nervous System Inflammation 100%
• Peroxisome Proliferator 100%
• Parkinson's Disease 100%
• Dopamine 44%
• Dopamine Receptor Stimulating Agent 33%
• Inflammation 33%
• Animal 11%
• Neuroprotection 11%
• Drug 11%
• Symptom 11%
• Free Radical 11%
• Nerve Degeneration 11%
• Nerve Cell Degeneration 11%
• Disease 11%
• Insulin 11%